# Remimazolam Versus Propofol for General Anesthesia Induction in Patients on Renin-angiotensin System Blockers Undergoing Robot-assisted Laparoscopic Prostatectomy

> **NCT06093971** · NA · COMPLETED · sponsor: **Yonsei University** · enrollment: 112 (actual)

## Conditions studied

- Prostate Tumor

## Interventions

- **DRUG:** remimazolam
- **DRUG:** Propofol

## Key facts

- **NCT ID:** NCT06093971
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-17
- **Primary completion:** 2024-10-22
- **Final completion:** 2024-10-22
- **Target enrollment:** 112 (ACTUAL)
- **Last updated:** 2024-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06093971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06093971, "Remimazolam Versus Propofol for General Anesthesia Induction in Patients on Renin-angiotensin System Blockers Undergoing Robot-assisted Laparoscopic Prostatectomy". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT06093971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*